Cardiac Arrhythmia Suppression Trial
http://dbpedia.org/resource/Cardiac_Arrhythmia_Suppression_Trial an entity of type: WikicatClinicalTrials
CAST (Cardiac Arrhythmia Suppression Trial) ist das Akronym einer von 1986 bis 1998 durchgeführten klinischen Studie über die Wirksamkeit von Arzneimitteln aus der Gruppe der Klasse-I-Antiarrhythmika zur Verhinderung des plötzlichen Herztodes nach einem Herzinfarkt. Die 1991 (CAST) und 1992 (CAST II) im New England Journal of Medicine publizierten Ergebnisse der Studie haben weltweit zu einem Paradigmenwechsel in der Behandlung von Infarktpatienten geführt und CAST zu einer der am meisten beachteten medizinischen Studien gemacht.
rdf:langString
The Cardiac Arrhythmia Suppression Trial (CAST) was a double-blind, randomized, controlled study designed to test the hypothesis that suppression of premature ventricular complexes (PVC) with class I antiarrhythmic agents after a myocardial infarction (MI) would reduce mortality. It was conducted between 1986 and 1989 and included over 1700 patients in 27 centres. The study found that the tested drugs increased mortality instead of lowering it as was expected. The publication of these results in 1991/92, in combination with large follow-up studies for drugs that had not been tested in CAST, led to a paradigm shift in the treatment of MI patients. Class I and III antiarrhythmics are now only used with extreme caution after MI, or they are contraindicated completely. Heart Rhythm Society Dis
rdf:langString
rdf:langString
CAST (Studie)
rdf:langString
Cardiac Arrhythmia Suppression Trial
xsd:integer
33224638
xsd:integer
1120797197
rdf:langString
CAST (Cardiac Arrhythmia Suppression Trial) ist das Akronym einer von 1986 bis 1998 durchgeführten klinischen Studie über die Wirksamkeit von Arzneimitteln aus der Gruppe der Klasse-I-Antiarrhythmika zur Verhinderung des plötzlichen Herztodes nach einem Herzinfarkt. Die 1991 (CAST) und 1992 (CAST II) im New England Journal of Medicine publizierten Ergebnisse der Studie haben weltweit zu einem Paradigmenwechsel in der Behandlung von Infarktpatienten geführt und CAST zu einer der am meisten beachteten medizinischen Studien gemacht.
rdf:langString
The Cardiac Arrhythmia Suppression Trial (CAST) was a double-blind, randomized, controlled study designed to test the hypothesis that suppression of premature ventricular complexes (PVC) with class I antiarrhythmic agents after a myocardial infarction (MI) would reduce mortality. It was conducted between 1986 and 1989 and included over 1700 patients in 27 centres. The study found that the tested drugs increased mortality instead of lowering it as was expected. The publication of these results in 1991/92, in combination with large follow-up studies for drugs that had not been tested in CAST, led to a paradigm shift in the treatment of MI patients. Class I and III antiarrhythmics are now only used with extreme caution after MI, or they are contraindicated completely. Heart Rhythm Society Distinguished Scientist D. George Wyse was a member of the CAST trial's steering and executive committees.
xsd:nonNegativeInteger
6209